Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells

L Scott, J Lamb, S Smith, D N Wheatley

    Research output: Contribution to journalArticle

    123 Citations (Scopus)

    Abstract

    The effects of arginine deprivation (-Arg) has been examined in 26 cell lines. Less than 10% of those with transformed or malignant phenotype survived for > 5 days, and many died more rapidly, notably leukaemic cells. Bivariate flow cytometry confirmed that vulnerable cell lines failed to move out of cell cycle into a quiescent state (GO), but reinitiated DNA synthesis. Many cells remained in S-phase, and/or had difficulty progressing through to G2 and M. Two tumour lines proved relatively 'resistant', A549 and MCF7. Although considerable cell loss occurred initially, both lines showed a 'cell cycle freeze', in which cells survived for > 10 days. These cells recovered their proliferative activity in +Arg medium, but behaved in the same manner to a second -Arg episode as they did to the first episode. In contrast, normal cells entered GO and survived in -Arg medium for several weeks, with the majority of cells recovering with predictable kinetics in +Arg medium. In general, cells from a wide range of tumours and established lines die quickly in vitro following -Arg treatment, because of defective cell cycle checkpoint stringency, the efficacy of the treatment being most clearly demonstrated in co-cultures in which only the normal cells survived. The findings demonstrate a potentially simple, effective and non-genotoxic strategy for the treatment of a wide range of cancers. (C) 2000 Cancer Research Campaign.

    Original languageEnglish
    Pages (from-to)800-810
    Number of pages11
    JournalBritish Journal of Cancer
    Volume83
    Publication statusPublished - 2000

    Keywords

    • arginine
    • growth
    • death
    • malignant cells
    • normal cells
    • PROTEIN-SYNTHESIS
    • GROWTH
    • PROLIFERATION
    • RESTRICTION
    • CANCER
    • TUMOR

    Cite this

    Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells. / Scott, L ; Lamb, J ; Smith, S ; Wheatley, D N .

    In: British Journal of Cancer, Vol. 83, 2000, p. 800-810.

    Research output: Contribution to journalArticle

    @article{71480e82fa3a420ead331a4b8ec0cfaf,
    title = "Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells",
    abstract = "The effects of arginine deprivation (-Arg) has been examined in 26 cell lines. Less than 10{\%} of those with transformed or malignant phenotype survived for > 5 days, and many died more rapidly, notably leukaemic cells. Bivariate flow cytometry confirmed that vulnerable cell lines failed to move out of cell cycle into a quiescent state (GO), but reinitiated DNA synthesis. Many cells remained in S-phase, and/or had difficulty progressing through to G2 and M. Two tumour lines proved relatively 'resistant', A549 and MCF7. Although considerable cell loss occurred initially, both lines showed a 'cell cycle freeze', in which cells survived for > 10 days. These cells recovered their proliferative activity in +Arg medium, but behaved in the same manner to a second -Arg episode as they did to the first episode. In contrast, normal cells entered GO and survived in -Arg medium for several weeks, with the majority of cells recovering with predictable kinetics in +Arg medium. In general, cells from a wide range of tumours and established lines die quickly in vitro following -Arg treatment, because of defective cell cycle checkpoint stringency, the efficacy of the treatment being most clearly demonstrated in co-cultures in which only the normal cells survived. The findings demonstrate a potentially simple, effective and non-genotoxic strategy for the treatment of a wide range of cancers. (C) 2000 Cancer Research Campaign.",
    keywords = "arginine, growth, death, malignant cells, normal cells, PROTEIN-SYNTHESIS, GROWTH, PROLIFERATION, RESTRICTION, CANCER, TUMOR",
    author = "L Scott and J Lamb and S Smith and Wheatley, {D N}",
    year = "2000",
    language = "English",
    volume = "83",
    pages = "800--810",
    journal = "British Journal of Cancer",
    issn = "0007-0920",
    publisher = "Nature Publishing Group",

    }

    TY - JOUR

    T1 - Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells

    AU - Scott, L

    AU - Lamb, J

    AU - Smith, S

    AU - Wheatley, D N

    PY - 2000

    Y1 - 2000

    N2 - The effects of arginine deprivation (-Arg) has been examined in 26 cell lines. Less than 10% of those with transformed or malignant phenotype survived for > 5 days, and many died more rapidly, notably leukaemic cells. Bivariate flow cytometry confirmed that vulnerable cell lines failed to move out of cell cycle into a quiescent state (GO), but reinitiated DNA synthesis. Many cells remained in S-phase, and/or had difficulty progressing through to G2 and M. Two tumour lines proved relatively 'resistant', A549 and MCF7. Although considerable cell loss occurred initially, both lines showed a 'cell cycle freeze', in which cells survived for > 10 days. These cells recovered their proliferative activity in +Arg medium, but behaved in the same manner to a second -Arg episode as they did to the first episode. In contrast, normal cells entered GO and survived in -Arg medium for several weeks, with the majority of cells recovering with predictable kinetics in +Arg medium. In general, cells from a wide range of tumours and established lines die quickly in vitro following -Arg treatment, because of defective cell cycle checkpoint stringency, the efficacy of the treatment being most clearly demonstrated in co-cultures in which only the normal cells survived. The findings demonstrate a potentially simple, effective and non-genotoxic strategy for the treatment of a wide range of cancers. (C) 2000 Cancer Research Campaign.

    AB - The effects of arginine deprivation (-Arg) has been examined in 26 cell lines. Less than 10% of those with transformed or malignant phenotype survived for > 5 days, and many died more rapidly, notably leukaemic cells. Bivariate flow cytometry confirmed that vulnerable cell lines failed to move out of cell cycle into a quiescent state (GO), but reinitiated DNA synthesis. Many cells remained in S-phase, and/or had difficulty progressing through to G2 and M. Two tumour lines proved relatively 'resistant', A549 and MCF7. Although considerable cell loss occurred initially, both lines showed a 'cell cycle freeze', in which cells survived for > 10 days. These cells recovered their proliferative activity in +Arg medium, but behaved in the same manner to a second -Arg episode as they did to the first episode. In contrast, normal cells entered GO and survived in -Arg medium for several weeks, with the majority of cells recovering with predictable kinetics in +Arg medium. In general, cells from a wide range of tumours and established lines die quickly in vitro following -Arg treatment, because of defective cell cycle checkpoint stringency, the efficacy of the treatment being most clearly demonstrated in co-cultures in which only the normal cells survived. The findings demonstrate a potentially simple, effective and non-genotoxic strategy for the treatment of a wide range of cancers. (C) 2000 Cancer Research Campaign.

    KW - arginine

    KW - growth

    KW - death

    KW - malignant cells

    KW - normal cells

    KW - PROTEIN-SYNTHESIS

    KW - GROWTH

    KW - PROLIFERATION

    KW - RESTRICTION

    KW - CANCER

    KW - TUMOR

    M3 - Article

    VL - 83

    SP - 800

    EP - 810

    JO - British Journal of Cancer

    JF - British Journal of Cancer

    SN - 0007-0920

    ER -